Long read single cell RNA sequencing reveals the isoform diversity of Plasmodium vivax transcripts
Brittany HazzardiD, Juliana M. SáiD, Angela C. Ellis, Tales Vicari PasciniiD, Shuchi N. Amin, Thomas E. WellemsiD, David SerreiD
Abstract
Plasmodium infections often consist of heterogenous populations of parasites at different developmental stages and with distinct transcriptional profiles, which complicates gene expression analyses. The advent of single cell RNA sequencing (scRNA-seq) enabled disentangling this complexity and has provided robust and stage-specific characterization of Plasmodium gene expression. However, scRNA-seq information is typically derived from the end of each mRNA molecule (usually the 3-end) and therefore fails to capture the diversity in transcript isoforms documented in bulk RNA-seq data. Here, we describe the sequencing of scRNA-seq libraries using Pacific Biosciences (PacBio) chemistry to characterize full-length Plasmodium vivax transcripts from single cell parasites. Our results show that many P. vivax genes are transcribed into multiple isoforms, primarily through variations in untranslated region (UTR) length or splicing, and that the expression of these isoforms is often developmentally regulated. Our findings demonstrate that long read sequencing can be used to characterize mRNA molecules at the single cell level and provides an additional resource to better understand the regulation of gene expression throughout the Plasmodium life cycle. Author SummarySingle cell RNA-sequencing is a valuable tool for identifying cell specific differences in heterogenous populations. However, scRNA-seq has limitations in assigning reads to genes of organisims with poorly annotated UTRs, due to the poly-A caputre utilized by some scRNA-seq technologies, this technical limitation also makes identifying transcript specific differences, like alternative splicing, difficult. Despite its importance in human disease the P. vivax genome annotation is still relatively sparce, especially in the UTRs, and very little is known about transcript differece in the different life stages of the parasite life cycle. Here, we utilize a modified version of 10X scRNA-seq technology to capture full length transcripts via PacBio sequencing from both sporozoite and blood stages of P. vivax. This allowed us to predict full length stage specific transcripts for P. vivax as well as identify important variation in the previously poorly annotated UTRs. These findings will aide in futhering our understanding of P. vivax transcript regulation across the life cycle stages.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 23
- FWCI
- 3.31
- Field percentile
- top 7%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Single-cell RNA sequencing of Plasmodium vivax sporozoites reveals stage- and species-specific transcriptomic signatures
Anthony A. Ruberto, Caitlin Bourke, … Ivo Müeller·PLoS neglected tropical diseasesPeer-reviewed·Aug 4, 2022
- Analysis of Plasmodium vivax schizont transcriptomes from field isolates reveals heterogeneity of expression of genes involved in host-parasite interactions
Sasha V. Siegel, Lia Chappell, … Julian C. Rayner·Scientific ReportsPeer-reviewed·Oct 7, 2020
- Single-cell transcriptomics of malaria parasites
Adam James Reid, Arthur M. Talman, … Mara Lawniczak·eLifePeer-reviewed·Mar 26, 2018
- Stage-aware transcriptomics reveals selective haplotype persistence in short-term ex vivo cultured Plasmodium vivax
Beka Raya Abagero, Franck Dumetz, … Eugenia Lo·bioRxiv·May 13, 2026
- Direct nanopore sequencing of mRNA reveals landscape of transcript isoforms in apicomplexan parasites
V. Vern Lee, Louise M. Judd, … Stuart A. Ralph·mSystemsPeer-reviewed·Mar 15, 2021
- Single-cell RNA profiling of Plasmodium vivax-infected hepatocytes reveals parasite- and host- specific transcriptomic signatures and therapeutic targets
A. A. Ruberto, S. P. Maher, … D. E. Kyle·bioRxiv·Feb 1, 2022